279 filings
Page 4 of 14
SC 13G
ndyrlsqrrc6u09rkc5t
28 Feb 23
Galera Therapeutics / Flynn James E ownership change
12:00am
8-K
3lnxgq
16 Feb 23
Entry into a Material Definitive Agreement
5:04pm
424B5
wxiu 8s7afnkgq
15 Feb 23
Prospectus supplement for primary offering
5:32pm
8-K
slyl zdrglc5se
15 Feb 23
Results of Operations and Financial Condition
8:24am
SC 13G
apglrfcvd
13 Feb 23
Galera Therapeutics / SECTORAL ASSET MANAGEMENT ownership change
3:03pm
SC 13D
s657ebvzsmylyfr
9 Feb 23
Galera Therapeutics / Blackstone Holdings I/II GP L.L.C. ownership change
4:49pm
SC 13D/A
e7m65saw2l 03pczy
6 Feb 23
Galera Therapeutics / Sofinnova Venture Partners IX ownership change
12:00am
8-K
ixlsiw68mx8t
25 Jan 23
Other Events
4:10pm
8-K
ouyj4sc
12 Dec 22
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
8:00am
8-K
av1gz6j
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:11pm
4
s81fw myccexv9hse
22 Nov 22
Galera Therapeutics / Robert A Beardsley ownership change
4:05pm
8-K
13pvoatlg9 g75e
9 Nov 22
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
7:06am
8-K
au1lgjkvz
26 Oct 22
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
1:41pm
4
hbjl8k7pweoz2
13 Sep 22
Galera Therapeutics / Robert A Beardsley ownership change
4:10pm
4
qjk78nbak ovqxpo8
2 Sep 22
Galera Therapeutics / Eugene P. Kennedy ownership change
4:15pm
3
cmwe3
2 Sep 22
Galera Therapeutics / Eugene P. Kennedy ownership change
4:10pm
8-K
8hss1lvyq
9 Aug 22
Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates
7:00am
4
38ox8y
20 Jul 22
Galera Therapeutics / Lawrence M Alleva ownership change
6:05am